ASCCT Webinar Topic Survey

A main benefit to ASCCT membership is access to free webinars on topics relevant to the society's mission. This survey is intended to gather information on members' opinions about the webinar program and ensure that it continues to offer value. Your responses are anonymous, so if you have nominated yourself as a speaker, please either indicate your name or contact the ASCCT secretary, Kristie Sullivan, separately. Thank you!

Question Title

* 1. How many ASCCT webinars have you viewed?

1-5

5-10

10-15

Question Title

* 2. If you have not participated in any webinars, why not?

Conflict due to another meeting/event at that specific time

No free time in general

Subject not interesting

Technical difficulties

Not enough notice provided

Other (please specify)

Question Title

* 3. What specific days are most convenient for you?

Monday

Tuesday

Wednesday

Thursday

Friday

Question Title

* 4. What times of day are most convenient for you?

Early morning

Late morning

Lunchtime

Early afternoon

Late afternoon

Question Title

* 5. Have you watched recordings of past webinars on the ASCCT site?

Yes

Question Title

* 6. If not, why not?

Was able to watch the webinar live

Cannot find the recording

Other (please specify)

Question Title

* 7. Which webinars were most useful/interesting to you? (check all that apply)

Threshold of Toxicological Concern – an approach for safety assessment and its applicability to cosmetics-related chemicals | Chihae Yang, Altamira, LLC and Molecular Networks

Medical Device Irritation Testing: An In Vitro Alternative | Kelly Coleman, Medtronic Biomaterials Dept

Developing Confidence in 21st-Century Risk Assessments | Craig Rowlands, Dow Chemical Company

COSMOS DB: A New Database of Toxicological Information to Support Knowledge Discovery | Mark Cronin, Liverpool John Moores University and COSMOS project coordinator

High Content Imaging Approaches in Neurotoxicology and Neurodegeneration Research | Marcel Leist, University of Konstanz and CAAT Europe

EURL ECVAM's Approach to Validation of Alternative Methods | Valerie Zhuang, EURL ECVAM

Using the AOP Framework to Develop HTS Assays for Thyroid-Disrupting Chemicals | Katie Paul, US EPA

The Role of Non-Animal Methods in the Regulation of Nanomaterials in the United States | Erik Janus, Steptoe and Johnson LLP (Recording not available)

Human Induced Pluripotent Stem Cell-derived Model Systems | Maureen Bunger, Cellular Dynamics

Incorporating New Technologies into Toxicity Testing and Risk Assessment | Russell Thomas, The Hamner Institutes for Health Science

The Virtual Embryo | Nicole Kleinstreuer, US EPA

Tox21 Program Update | Raymond Tice, National Toxicology Program, NIH

Evidence-Based Toxicology (EBT) for the 21st Century | Martin Stephens, Johns Hopkins University

Effectopedia: The Online Encyclopedia of Adverse Effect Pathways | Gilman Veith and Hristo Aladjov, International QSAR Foundation

MetaPath: A Metabolism Pathway Database | Patricia Schmeider, US EPA

Question Title

* 8. What topics would you like to see given as future webinars? (Please provide additional details in the comment box)

Testing policies/requirements

Cosmetics testing approaches

Personal Care testing approaches

Chemical testing approaches

Pesticide testing approaches

Nanotoxicology approaches

Availability of chemical data/databases

QSAR or computational approaches

In vitro technologies (iPS cells, microphysiological models, metabolic capacity)

Federal agency initiatives or policies

Updates from ICCVAM, ECVAM, etc.

Progress or methods/strategies for specific endpoints

OECD Adverse Outcome Pathways Programme or other OECD programs

Specific AOPs

"Breaking" research reports

Additional Detail or topics

ASCCT Webinar Topic Survey

Question Title

* 1. How many ASCCT webinars have you viewed?

Question Title

* 2. If you have not participated in any webinars, why not?

Question Title

* 3. What specific days are most convenient for you?

Question Title

* 4. What times of day are most convenient for you?

Question Title

* 5. Have you watched recordings of past webinars on the ASCCT site?

Question Title

* 6. If not, why not?

Question Title

* 7. Which webinars were most useful/interesting to you? (check all that apply)

Question Title

* 8. What topics would you like to see given as future webinars? (Please provide additional details in the comment box)

Question Title

* 9. Please suggest specific webinar speakers, including yourself.

Question Title

* 10. Please provide any other comments/suggestions.